Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Clin Cancer Res. 2019 Nov 15;26(1):46–53. doi: 10.1158/1078-0432.CCR-18-4180

Figure 1.

Figure 1.

Kaplan–Meier curves for PFS in (A) BRAFi-naive cohort and (B) vemurafenib monotherapy–PD cohort. Abbreviations: BRAFi, BRAF inhibitor; PD, progressive disease; PFS, progression-free survival.